Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

AIDS-defining cancers in Western Europe, 1994-2001.

Shahul H Ebrahim1, A S M Abdullah, Matthew McKenna

  • 1National Center for HIV/AIDS, STD, TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA. Sbe2@cdc.gov

AIDS Patient Care and Stds
|January 6, 2005
PubMed
Summary

AIDS-defining cancers declined overall in Western Europe, with Kaposi's sarcoma decreasing among men and cervical cancer decreasing among young women. Lymphomas increased in both males and females with AIDS.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The PHEIC Threshold: What Ebola Has That Hantavirus Does Not.

Journal of travel medicine·2026
Same author

The 2026 Ebola Outbreak and Mass Gathering Risk.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026
Same author

Arson attacks at Ebola hospitals are a cry for regional development.

Nature·2026
Same author

Hantavirus at the hajj: decoupling perceived risk from epidemiological reality.

Journal of travel medicine·2026
Same author

HIV/AIDS in Conflict-Affected Countries, 2024-2025.

Journal of epidemiology and global health·2026
Same author

Congo's conflicts, minerals and microbes: planetary health implications.

BMJ global health·2026

Area of Science:

  • Epidemiology
  • Oncology
  • Public Health

Background:

  • Acquired Immunodeficiency Syndrome (AIDS)-defining cancers represent a significant public health concern.
  • Understanding trends in these cancers is crucial for monitoring the HIV/AIDS epidemic and informing prevention strategies.
  • Previous trends indicated varying incidence rates across different cancer types and demographic groups.

Purpose of the Study:

  • To analyze recent trends in AIDS-defining cancers in Western Europe.
  • To identify changes in the proportion of specific cancers as initial AIDS-defining illnesses.
  • To examine these trends across different demographic groups, including males and females.

Main Methods:

  • Analysis of the June 2002 European Non-Aggregate AIDS Data Set.

Related Experiment Videos

  • Inclusion of individuals aged 15 years or older diagnosed with AIDS between 1994 and 2001 (n = 125,691).
  • Calculation of percentages for AIDS-defining cancers as the initial AIDS-defining illness.

    • Main Results:

    • Overall decline in AIDS diagnoses and proportion of homosexual/bisexual and intravenous drug users.
    • Decrease in Kaposi's sarcoma (KS) among males, particularly homosexual/bisexual men, from 1994-2001.
    • Increase in lymphomas (all types) among males and females; cervical cancer declined among young females and heterosexuals.

    Conclusions:

    • The two leading AIDS-defining cancers at initial diagnosis showed declines in specific populations.
    • Kaposi's sarcoma decreased among men with sexually transmitted HIV infection.
    • Cervical cancer incidence declined among young females and heterosexual individuals.